DANIELLE HANNIGAN: Open Payments
NPI 1417257247 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$766 in 7 payments from 6 companies in 2025. Trend: 2023 $1,375 · 2024 $517 · 2025 $766
Food & beverage: $766
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $154 |
| E.R. Squibb & Sons, L.L.C. | 1 | $144 |
| Vanda Pharmaceuticals Inc. | 1 | $123 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $117 |
| Alkermes, Inc. | 1 | $105 |
Products named: Auvelity, COBENFY, FANAPT, AUSTEDO XR, CAPLYTA, ARISTADA.
Industry payments across IL — which companies pay providers there.
